Part,  Chapter, Paragraph

1   II,     5.  4.  8|      10 October 2008)~EURODIAB ACE Study Group (2000): Variation
2   II,     5.  7.  7|   subsequent treatment with an ACE inhibitor to prevent cardiovascular
3   II,     9        | angiotensin-converting enzyme (ACE) inhibitors reduce risk
4   II,     9.  3.  1| angiotensin-converting enzyme (ACE) inhibitors reduce risk
5  III,    10.  2.  4|        time (e.g., the role of ACE insertion-deletion polymorphism
6  III,    10.  2.  4|  meta-analysis establishes the ACE insertion-deletion polymorphism